DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.

Among patients with PD-1/PD-L1-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), treatment with ...

Imagine being armed with precautionary measures to fight a disease – like being vaccinated before the flu season arrives. What if we could have a similar kind of preparedness for a dangerous disease ...

Janssen-Cilag International NV, part of Johnson & Johnson, has announced encouraging results from the phase 1b/2 OrigAMI-4 ...

Head and neck cancer is the sixth most common cancer worldwide, with around 12,800 new cases each year in the UK alone ...

The first vaccines, approved in 2006, protects against four strains, HPV-6, HPV-11, HPV-16 and HPV-18. Another, approved in 2009, protects against two high-risk strains, HPV-16 and HPV-18. The third, ...

Dear Dr. Roach: I am a healthy 69-year-old female. I walk every day and belong to an exercise group that I attend twice a ...

The researchers highlighted that by catching cancers early, patients may experience higher treatment success and require a ...

Cancer screenings are a vital part of a woman’s reproductive and overall health. While breast cancer is the most common reproductive cancer in women, cervical cancer is the third most common type of ...

Investing.com -- Genmab A/S (CSE:GMAB) shares fell more than 3% on Monday after new data from Johnson & Johnson ’s amivantamab suggested the drug could rival Genmab and Merus N.V. ’s petosemtamab in ...

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

When Sean Fletcher walked into Sam Biswas' Medical and Molecular Sciences (MMSC) lab at the University of Delaware College of ...